Vaxcyte

Medical Science Liaison

Vaxcyte$184K — $215K *
Pharmaceuticals & Biotech
5 - 7 years of experience
Job Overview by Ladders

Qualifications

  • Advanced degree (PhD, PharmD, MD, MPH) in life sciences, immunology, or public health preferred.
  • Minimum 5 years experience in medical affairs, clinical research, or infectious disease.
  • Strong knowledge of immunology and vaccine development.
  • Excellent communication skills for scientific and public health audiences.
  • Ability to travel up to 70% of the time.
  • Other combinations of education and/or experience may be considered.

Responsibilities

  • Build and maintain scientific relationships with key opinion leaders and stakeholders.
  • Communicate epidemiological, clinical, and real-world data on pneumococcal disease and candidate vaccines.
  • Support investigator-initiated studies and clinical trial recruitment as needed.
  • Gather and share field insights on pneumococcal disease and vaccine data needs.
  • Represent the company at scientific meetings and stakeholder events.
  • Uphold ethical standards in all field activities.

Benefits

  • Comprehensive benefits package.
  • Equity component.
Full Job Description
Summary:

We are seeking a scientifically driven and communicative Medical Science Liaison (MSL) to join our Medical Affairs team. The Medical Science Liaison (MSL) serves as a scientific expert in immunization and pneumococcal disease prevention. This field-based role will serve as a trusted scientific partner to healthcare providers, public health officials, and key opinion leaders (KOLs) to support vaccine education, clinical development, and real-world evidence generation.

Depending on experience, the role may be leveled at Senior MSL, offering expanded responsibilities in strategic leadership and mentorship.
Essential Functions:
  • Stakeholder Management: Build and maintain scientific relationships with key opinion leaders, clinicians, researchers, and public health stakeholders.
  • Scientific Engagement: Communicate epidemiological, clinical and real-world data regarding pneumococcal disease and Vaxcyte's candidate vaccine.
  • Evidence Generation Support: Where relevant, support investigator-initiated studies and clinical trial recruitment in vaccine research.
  • Insight Collection and cross-functional collaboration: Gather and share field insights on pneumococcal disease landscape, vaccine data needs, and recommendation scenarios.
  • Education and Engagement: Represent the company at scientific meetings, conferences, and stakeholder events.
  • Compliance: Uphold ethical standards and regulatory guidelines in all field activities.
Requirements:
  • Advanced degree (PhD, PharmD, MD, MPH) in life sciences, immunology, or public health preferred.
  • A minimum of 5 years of experience in medical affairs, clinical research, or infectious disease.
  • Strong knowledge of immunology and vaccine development.
  • Excellent communication skills with ability to address scientific and public health audiences.
  • Travel: MSL positions are field-based and require significant travel, which can vary depending on the assigned territory.
  • Ability to travel up to 70% of the time.
  • Other combinations of education and/or experience may be considered.

Reports to: Senior Director, Medical Affairs

Location: Remote - United States

Compensation:

The compensation package will be competitive and includes comprehensive benefits and an equity component.

Salary Range: $184,000 - $215,000

About Vaxcyte

Vaxcyte is a clinical-stage biotechnology company developing a new generation of vaccines to address some of the most important and deadly infectious diseases worldwide. The company's cell-free protein synthesis platform, comprising the XpressCFTM platform, is capable of rapidly generating protein antigens that can be used in vaccines to protect against bacterial and viral pathogens. Vaxcyte's lead vaccine candidate, VAX-24, is a preclinical, 24-valent pneumococcal conjugate vaccine (PCV) being developed for the prevention of pneumococcal disease. The company is also developing VAX-XP, a PCV with expanded serotype coverage, as well as vaccines for Group A Streptococcus, Group B Streptococcus, and Lyme disease.
Learn more about Vaxcyte
Size
89 employees
Market Cap
$3.6 billion
Industry
Founded
2013
NASDAQ

Similar Jobs

More Jobs at Vaxcyte

More Pharmaceuticals & Biotech Jobs

Find similar Medical Science Liaison jobs: